---
figid: PMC7106881__BMRI2020-7806860.009
figtitle: Hypothetical action mechanism of aspirin on nonalcoholic fatty liver and
  atherosclerosis
organisms:
- Oryctolagus cuniculus
- Homo sapiens
organisms_ner:
- Homo sapiens
- Oryctolagus cuniculus
- Drosophila melanogaster
pmcid: PMC7106881
filename: BMRI2020-7806860.009.jpg
figlink: pmc/articles/PMC7106881/figure/fig9/
number: F9
caption: Hypothetical action mechanism of aspirin on nonalcoholic fatty liver and
  atherosclerosis. Simultaneous amelioration of both nonalcoholic fatty liver and
  atherosclerosis by aspirin is mainly achieved by catabolic activation, anti-inflammation,
  or vasodilation, which are the result of sequential regulation of the PPARδ→p-AMPK→PGC-1α→oxidative
  phosphorylation pathway. In addition, the effects of aspirin are achieved by macrophage
  modulations, which include the increase of mannose receptor and decrease of CCR2.
papertitle: Aspirin Improves Nonalcoholic Fatty Liver Disease and Atherosclerosis
  through Regulation of the PPARδ-AMPK-PGC-1α Pathway in Dyslipidemic Conditions.
reftext: Yoon-Mi Han, et al. Biomed Res Int. 2020;2020:7806860.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8306529
figid_alias: PMC7106881__F9
figtype: Figure
redirect_from: /figures/PMC7106881__F9
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7106881__BMRI2020-7806860.009.html
  '@type': Dataset
  description: Hypothetical action mechanism of aspirin on nonalcoholic fatty liver
    and atherosclerosis. Simultaneous amelioration of both nonalcoholic fatty liver
    and atherosclerosis by aspirin is mainly achieved by catabolic activation, anti-inflammation,
    or vasodilation, which are the result of sequential regulation of the PPARδ→p-AMPK→PGC-1α→oxidative
    phosphorylation pathway. In addition, the effects of aspirin are achieved by macrophage
    modulations, which include the increase of mannose receptor and decrease of CCR2.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CCR2
  - TNF
  - FAS
  - FASN
  - HMGCR
  - CD36
  - FAT1
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - PPARGC1A
  - NOS3
  - ENO4
  - ATP8A2
  - ti
  - egr
  - bi
  - Fas2
  - FASN1
  - Fas3
  - fand
  - tei
  - rg
  - FASN2
  - FASN3
  - Hmgcr
  - vi
  - Sh
  - ple
  - Eig71Ee
  - l(2)46Da
  - anon-48Ae
  - ft
  - kug
  - faf
  - SNF4Agamma
  - AMPKalpha
  - srl
  - ATPsynbeta
  - Atpalpha
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Aspirin
  - Mannose
  - Ti
  - Bi
  - ATP
  - Atherosclerosis
  - atherosclerosis
---
